The effect of irbesartan on the development of diabetic nephropathy in patients with type 2 diabetes.
Parving HH; Lehnert H; Bröchner-Mortensen J; Gomis R; Andersen S; Arner P; The New England Journal Of Medicine, 2001, vol. 345, issue 12, p 870, ISSN 00284793. ISBN 00284793.
Full Text Resources Located for this Citation